Medtronic
MDT
1,280 hedge funds and large institutions have $98.3B invested in Medtronic in 2017 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 467 increasing their positions, 542 reducing their positions, and 83 closing their positions.
34% more funds holding in top 10
Funds holding in top 10: 47 → 63 (+16)
13% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 83
8% more capital invested
Capital invested by funds: $91B → $98.3B (+$7.29B)
0% less funds holding
Funds holding: 1,283 → 1,280 (-3)
1.05% less ownership
Funds ownership: 82.51% → 81.46% (-1%)
14% less repeat investments, than reductions
Existing positions increased: 467 | Existing positions reduced: 542
23% less call options, than puts
Call options by funds: $357M | Put options by funds: $462M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$566M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$295M |
| 3 |
BlackRock
New York
|
+$209M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$207M |
| 5 |
Sanders Capital
West Palm Beach,
Florida
|
+$171M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$878M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$510M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$459M |
| 4 |
Morgan Stanley
New York
|
-$330M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$214M |
MDT Hedge Fund Activity: Q2 2017 in Review
1,280 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2017, worth a combined $98.3B — up 8% from $91B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new MDT positions and 83 closed out — a net gain of 11 holders — while 467 added to existing stakes and 542 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $566M. The largest seller was Wellington Management Group, cutting an estimated $878M.
- 1,280 institutional investors held Medtronic (MDT) as of Q2 2017, down from 1,283 in Q1 2017.
- Funds reported $98.3B of Medtronic stock for Q2 2017, up 8% quarter-over-quarter.
- 94 funds opened new Medtronic positions in Q2 2017 and 83 closed out, a net change of +11 holders.
- The largest Medtronic buyer in Q2 2017 was Lazard Asset Management, an estimated $566M added.
- The largest Medtronic seller in Q2 2017 was Wellington Management Group, an estimated $878M sold.
Based on aggregated 13F filings for Q2 2017.